Related Experiment Video
Updated: Jun 12, 2026
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.
Jun R Chiong1, Rebecca J Cheung
1Department of Medicine, Cardiology Division, Loma Linda University School of Medicine, Loma Linda, California 92354, USA. jchiong@llu.edu
Clinical Cardiology
|June 18, 2010
Summary
Loop diuretics offer symptomatic relief for acute decompensated heart failure (ADHF) but do not improve long-term mortality. High doses of these diuretics may lead to adverse effects, including worsened kidney function.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure (HF) is a prevalent condition with significant healthcare costs, morbidity, and mortality.
- Current treatments for acute decompensated heart failure (ADHF) have yielded neutral results, positioning loop diuretics as a primary therapy.
Purpose of the Study:
- To review the existing evidence on the risks and benefits of loop diuretics in the management of ADHF.
- To evaluate the association between loop diuretic use and patient outcomes in ADHF.
Main Methods:
- A comprehensive literature search of MEDLINE was conducted.
- Articles focusing on heart failure and loop diuretics were identified and reviewed.
Main Results:
- Loop diuretics provide symptomatic improvements, including reduced congestion, increased urine output, and weight loss.
- No long-term mortality benefit has been demonstrated with loop diuretic use.
- High doses of loop diuretics are linked to negative outcomes, such as impaired renal function.
Conclusions:
- Loop diuretics remain valuable in HF management.
- Further well-designed prospective studies are necessary to fully understand the risk-benefit profile of loop diuretics in ADHF.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...